Welltower has been on a powerful multi year run, which naturally raises a simple question for anyone looking at the stock today: Is the current share price of US$245.01 still grounded in the cash flows the real estate investment trust is expected to generate, or has sentiment moved ahead of the underlying money coming in the door?
The issue now is whether those projected cash flows, as captured by a Discounted Cash Flow (DCF) intrinsic value estimate, are enough to warrant where Welltower trades today.
If you are assessing whether Welltower's US$245.01 share price aligns with its cash flow profile and want more ideas based on similar valuation work, a focused screener of 39 high quality undervalued stocks can be a useful next step.
The Discounted Cash Flow (DCF) model here looks at the cash Welltower could return to shareholders over time and then discounts that back into today's dollars. On this view, the trust generated about $1.82b of adjusted free cash flow over the last twelve months, and the projections assume that figure increases meaningfully over the coming decade rather than shrinking. That trajectory relies on the idea that its healthcare focused properties continue producing steady rental income that can be passed through after costs and capital spending.
The long range forecast points to free cash flow comfortably above $6b a year by 2030, so the market is already factoring in a sizable uplift versus the recent run rate. With the DCF suggesting an intrinsic value that sits modestly below the current US$245.01 share price, the market price implies relatively optimistic expectations around how much cash Welltower can eventually generate from its portfolio. Find out what Welltower could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives pick up where the valuation puzzle for Welltower leaves off by spelling out which paths for future growth, profitability and earnings would need to occur for the REIT to be worth materially more or less than it is today, and they sit on the stock's Community page for you to review. Each scenario links a fair value estimate to a specific set of potential catalysts and risks so you can track over time which storyline appears to be unfolding.
Community views on Welltower split between those who see more upside left in the senior housing thesis and those who worry the valuation already reflects a lot of that story.
Bull case: 7% undervalued
"Welltower has launched a private fund management business that now includes a fully committed US$2.5b U.S. seniors housing equity fund and an approximately US$750m debt fund, which can add fee-based, capital-light revenue alongside rental income and support earnings growth..."
Discover why this Narrative puts Welltower at 7% undervalued.
Bear case: 7% overvalued
"Welltower currently has a market capitalization of roughly US$145 billion and offers a dividend yield of approximately 1.4%, which is below the broader healthcare REIT industry average of around 5%..."
Explore why this Narrative puts Welltower at 7% overvalued.
Welltower's share price and cash flows are only part of the story, because the people choosing where to invest capital and how they are rewarded can heavily shape what happens next for shareholders. See who runs Welltower and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com